Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrianus C M Boon

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Journal of Virology|August 27, 2009
Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in miceAdrianus C M Boon, Jennifer deBeauchamp, Anna Hollmann, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2020
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activitiesCaleb D Swaim, Yi-Chieh Perng, Xu Zhao, et al.
Journal of Virology|August 29, 2025
Ciliated cells promote high infectious potential of influenza A virus through the efficient intracellular activation of hemagglutininZijian Guo, Victoria S Banas, Yuanyuan He, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Efficacy of Host Cell Serine Protease Inhibitor MM3122 against SARS-CoV-2 for Treatment and Prevention of COVID-19Adrianus C M Boon, Traci L Bricker, Ethan J Fritch, et al.
Journal of Virology|September 4, 2024
Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamstersNadia Soudani, Traci L Bricker, Tamarand Darling, et al.
European Journal of Medicinal Chemistry|November 25, 2025
Inhibitors of membrane associated serine proteases block replication of coronavirus SARS-CoV-2 and influenza virus H1N1Victoria Banas, Kuljeet Seehra, Matthew Mahoney, et al.
Journal of Virology|April 9, 2024
Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19Adrianus C M Boon, Traci L Bricker, Ethan J Fritch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytesAdrianus C M Boon, Gerrie de Mutsert, Debbie van Baarle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2026
Identification of immunodominant T cell epitopes in SARS-CoV-2 spike protein in Syrian hamstersNadia Soudani, John Sidney, Ricardo Da Silva Antunes, et al.
Virology|April 23, 2016
Residues in the PB2 and PA genes contribute to the pathogenicity of avian H7N3 influenza A virus in DBA/2 miceBrittany L DesRochers, Rita E Chen, Anshu P Gounder, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Journal of Virology|August 27, 2009
Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in miceAdrianus C M Boon, Jennifer deBeauchamp, Anna Hollmann, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2020
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activitiesCaleb D Swaim, Yi-Chieh Perng, Xu Zhao, et al.
Journal of Virology|August 29, 2025
Ciliated cells promote high infectious potential of influenza A virus through the efficient intracellular activation of hemagglutininZijian Guo, Victoria S Banas, Yuanyuan He, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Efficacy of Host Cell Serine Protease Inhibitor MM3122 against SARS-CoV-2 for Treatment and Prevention of COVID-19Adrianus C M Boon, Traci L Bricker, Ethan J Fritch, et al.
Journal of Virology|September 4, 2024
Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamstersNadia Soudani, Traci L Bricker, Tamarand Darling, et al.
European Journal of Medicinal Chemistry|November 25, 2025
Inhibitors of membrane associated serine proteases block replication of coronavirus SARS-CoV-2 and influenza virus H1N1Victoria Banas, Kuljeet Seehra, Matthew Mahoney, et al.
Journal of Virology|April 9, 2024
Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19Adrianus C M Boon, Traci L Bricker, Ethan J Fritch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytesAdrianus C M Boon, Gerrie de Mutsert, Debbie van Baarle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2026
Identification of immunodominant T cell epitopes in SARS-CoV-2 spike protein in Syrian hamstersNadia Soudani, John Sidney, Ricardo Da Silva Antunes, et al.
Virology|April 23, 2016
Residues in the PB2 and PA genes contribute to the pathogenicity of avian H7N3 influenza A virus in DBA/2 miceBrittany L DesRochers, Rita E Chen, Anshu P Gounder, et al.
Pageof 11